Elements of Pharmaceutical/Biotech Pricing I – Introduction will give participants a basic understanding of the key terminology and issues involved in pharmaceutical pricing decisions. It will cover the tools to build and document product value, including issues, information, and processes employed (including pricing research); the role of pharmacoeconomics; and the differences in payment systems that help to shape pricing decisions. These tools will be further explored through a series of interactive exercises. This course is designed for those with limited experience in the area of pharmaceutical pricing and will cover topics within a global context.
In Case Studies in Pharmaceutical/Biotech Pricing II – Advanced, case studies will be employed to lead participants through the key steps of new product pricing, with focus on the need to thoroughly analyze the business environment and its constraints and opportunities, and the need to closely integrate the pricing, reimbursement, and pharmacoeconomic strategy for the new product with the clinical development and marketing strategies. Practical exercises will allow participants to consolidate the concepts delivered in the “Elements” introductory session and expanded here. Areas covered will include the post-launch issues of reimbursement and pricing maintenance as a part of life-cycle management in a global environment. This course is designed for those with limited experience in the area of pharmaceutical pricing and covers topics within a global context. Participation in the short course “Elements of Pharmaceutical/Biotech Pricing I – Introduction” or equivalent knowledge is required.
For more information on the conference, please visit the ISPOR Web site.For additional information about these courses or Medical Marketing Economics®, please contact us at +1 662.281.0502 or via e-mail at firstname.lastname@example.org